Insider Transactions in Q1 2026 at Natera, Inc. (NTRA)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2026
|
Jonathan Sheena |
BUY
Grant, award, or other acquisition
|
Direct |
7,450
+2.68%
|
-
|
|
Jan 14
2026
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,248
+13.16%
|
-
|
|
Jan 14
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
BUY
Grant, award, or other acquisition
|
Direct |
44,698
+21.0%
|
-
|
|
Jan 14
2026
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
44,698
+18.62%
|
-
|
|
Jan 14
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
152,718
+34.55%
|
-
|
|
Jan 14
2026
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
59,596
+32.51%
|
-
|
|
Jan 05
2026
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
39,615
+13.11%
|
$356,535
$9.59 P/Share
|
|
Jan 02
2026
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,848
-1.38%
|
$881,192
$229.15 P/Share
|
|
Jan 02
2026
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
2,951
-1.17%
|
$672,828
$228.88 P/Share
|